Literature DB >> 3318974

Transformation of Trypanosoma cruzi trypomastigote bloodstream forms by immune IgM and its Fab mu fragment into activators of the alternative complement pathway.

T L Kipnis1, M Sucupira, W D da Silva.   

Abstract

1. We report that purified immune IgM obtained from Chagasic patients during the chronic stage of the disease and also immune IgM and its Fab mu fragments obtained from chronically T. cruzi-infected mice are capable of preparing trypomastigote forms of T. cruzi to be lysed by complement. 2. Mouse strains susceptible, moderately susceptible and resistant to T. cruzi infection are equally capable of producing antibodies with lytic activity as well as antibodies detectable by immunofluorescence and by immunoenzymatic assay. 3. The epitopes recognized by polyclonal lytic antibodies are present on the surface of trypomastigotes from many different strains and stocks of T. cruzi.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318974

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  3 in total

1.  Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

2.  Genetically Determined MBL Deficiency Is Associated with Protection against Chronic Cardiomyopathy in Chagas Disease.

Authors:  Paola Rosa Luz; Márcia I Miyazaki; Nelson Chiminacio Neto; Marcela C Padeski; Ana Cláudia M Barros; Angelica B W Boldt; Iara J Messias-Reason
Journal:  PLoS Negl Trop Dis       Date:  2016-01-08

3.  Comparison of the C-mediating killing activity and C-activating properties of mouse monoclonal and polyclonal antibodies against Trypanosoma cruzi.

Authors:  T L Kipnis; D V Tambourgi; M J Alves; W D Silva
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.